跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAGLIPTINA/METFORMINA PHARMATHEN 50 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SITAGLIPTINA/METFORMINA PHARMATHEN 50 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
SITAGLIPTINA/METFORMINA PHARMATHEN 50 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Pharmathen S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 12, 2024
Approval ID
5d675d05ce98484c
Company
Pharmathen S.A.
Type
Standard
Approval Details
Approval Id
5d675d05ce98484c
Drug Cima Aemps Name
SITAGLIPTINA/METFORMINA PHARMATHEN 50 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89701
Holder Company Name
Pharmathen S.A.
Marketing Company Name
Pharmathen S.A.
Holder Company Detail Path
/organization/pharmathen-s-a
Marketing Company Detail Path
/organization/pharmathen-s-a
Authorization Date
2024-07-12
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
50 mg/850 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Pharmathen S.A.
Company Detail Path
/organization/pharmathen-s-a
Company Information
Pharmaceutical Company Name
PHARMATHEN S.A.
Country Name
Greece
City Name
pallini,sterea ellada and evoia,country_gr
Address
6 Dervenakion
Active Ingredients
SITAGLIPTINA HIDROCLORURO MONOHIDRATO
56,68 mg
METFORMINA HIDROCLORURO
850 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 12, 2024
Approval ID
5d675d05ce98484c
Type
Standard
Back to CIMA-AEMPS Approvals